The Lowdown on Cancer focuses on the impact of cancer on lives and on the things that give us hope. From the pain of learning you have cancer to innovative new treatments offered by the best and brightest, we’ll give you the Lowdown.
Yes, cancer sucks. But you are not alone. And we are not without hope!
It's a question we are getting a lot these days: Should cancer patients get the new COVID Vaccine? We asked renowned oncologist, Dr. Rachna Shroff, for her take on the safety and risks of the vaccine. Dr. Shroff provides a comprehensive look at the...
Meet Greg O'Ryan Johnson, Venture Scout Associate. In his role at the CANCER FUND, Greg contributes by evaluating early stage companies through due diligence and analytical processes. Greg’s mission while at the CANCER FUND is to help entrepreneurs bring...
The innovators we speak with all have one major thing in common - yes, they're part of the fight against cancer, but more pressing is that the only road to the finish line requires FUNDING. That's why CANCER FUND was formed. We invest in cancer...
Meet Ajay Bhatnagar, MD, MBA, CANCER FUND's Chief Medical Officer, a practicing radiation oncologist, and a diverse business investor. Learn about his involvement with CANCER FUND, and how we are unlike any other firm in the investment space. In his...
Some people are surprised when they learn that CANCER FUND is an investment firm. But the folks behind the scenes aren’t a bunch of Wall Street suits, we are real people, motivated to make a real impact in the lives of cancer patients and their loved...
It’s time to take a step back and pull aside the curtain to share with you the story behind CANCER FUND. Please join Ann as she speaks with CANCER FUND founder, Anthony Bajoras, for a very raw, emotional look at how this organization came to be, and how...
The Lowdown on Cancer was created to inspire and empower individuals touched by cancer to take an active role in bringing innovation to patients. If you're part of our community, then you're likely familiar with co-founder Ann Low. We wanted to take a...
The Problem Mihir’s Story Meet Mihir Vora, one of CANCER FUND’s early supporters and collaborators. His story is likely to sound like many you’ve heard before. A healthy, typical life: Education, job, marriage. Everything going in the right direction. And...
Join us for our next journey: Is The Race for a Cure Stalled on a Treadmill? We’re diving in to give you a better look at why and how the CANCER FUND was created, and what work we are doing to improve the lives of cancer patients and those who love them....
Thank you for joining us on the journey to explore cancer recurrence in our series “The Bitch Is Back.” Cancer recurrence rates vary widely depending on the type of cancer and other factors, but occurs in roughly 70% of cancer patients, with higher rates...
Tune in for a quick recap of our four innovators as they explain the products their teams are working on to battle cancer recurrence. https://youtu.be/Jl4UiXnrQ_M
Happy Thanksgiving from all of us at the CANCER FUND! https://youtu.be/elvieEws3Y4
Meet Richard Austin, CEO/President of Reglagene, a company out to discover and develop low-cost and noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment....
Meet David Lu, a research scientist at the Yale Cancer Biology Institute and co-founder of Celestra Life Science. Learn about David and his team at Celestra, where they are combining innovations in synthetic lethality and nanotechnology to develop a new...
Meet Darren Cunningham, CEO of Inflection BioSciences, an early-stage drug development company focused on discovering and developing innovative small molecule therapeutics to treat cancer and cancer recurrences. https://youtu.be/26GsLg7uj9o
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.